Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLendinvest Regulatory News (LINV)

Share Price Information for Lendinvest (LINV)

Share Price is delayed by 15 minutes
Get Live Data
24.50    -0.70 (-2.78%)
Bid:
24.00
Ask:
25.00
Spread: 1.00 (4.167%)
Market Cap: £34.70m
LINV Live PriceLast checked at - London Stock Exchange

Intraday Lendinvest Share Chart

Publication of a Base Prospectus

14 Oct 2025 10:49

RNS Number : 3029D
Lendinvest PLC
14 October 2025
 

PUBLICATION OF BASE PROSPECTUS

The following base prospectus dated 13 October 2025 (the "Base Prospectus") has been approved by the UK Financial Conduct Authority and is available for viewing:

 

Base Prospectus dated 13 October 2025 for the LendInvest Secured Income III plc £1,000,000,000 Euro Medium Term Note Programme with the benefit of a partial 20% guarantee by LendInvest plc.

Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.

To view the full document, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/3029D_1-2025-10-14.pdf

 

A copy of the Base Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

LendInvest 

Hugo Davies, Chief Capital Officer & Managing Director LI Mortgages

Frederick Newman, Director of Treasury MarketsChris Semple, Head of Corporate Communications & Investor Relations

Email: investorrelations@lendinvest.com 

Telephone:

+44 (0)20 3747 4187

Allia C&C Ltd

Mark Glowrey

Telephone:

+44 (0)20 3039 3465

 

DISCLAIMER - INTENDED ADDRESSEES

IMPORTANT: You must read the following before continuing.

The following applies to the Base Prospectus available by clicking on the link above, and you are therefore advised to read this carefully before reading, accessing or making any other use of the Base Prospectus. In accessing the Base Prospectus, you agree to be bound by the following terms and conditions, including any modifications to them, any time you receive any information from us as a result of such access.

Please note that the information contained in the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

The Base Prospectus has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of LendInvest Secured Income III plc, LendInvest plc, their respective advisers or any person who controls LendInvest Secured Income III plc or LendInvest plc or any director, officer, employee or agent of LendInvest Secured Income III plc or LendInvest plc or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Base Prospectus made available to you in electronic format and the hard copy version available to you on request from LendInvest Secured Income III plc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIGCBDGLSBDGUS
Date   Source Headline
29th Apr 20268:00 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSLendInvest FY26 Trading Update
28th Jan 20264:18 pmRNSHolding(s) in Company
28th Jan 20264:13 pmRNSDirector/PDMR Shareholding
28th Jan 20264:11 pmRNSDirector/PDMR Shareholding
26th Jan 20267:00 amRNSLendInvest announces FuM has increased to £5.44bn
6th Jan 20261:38 pmRNSHolding(s) in Company
18th Dec 20255:51 pmRNSHolding(s) in Company
18th Dec 20255:51 pmRNSHolding(s) in Company
18th Dec 20255:44 pmRNSDirector/PDMR Shareholding
18th Dec 20255:44 pmRNSDirector/PDMR Shareholding
17th Dec 20255:38 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSReplacement LendInvest H1 FY26 Financial Statement
8th Dec 20257:00 amRNSLendInvest plc H1 FY26 Interim Financial Statement
14th Nov 20256:00 pmRNSPublication of Amended and Restated Final Terms
14th Nov 20252:49 pmRNSLendInvest III Notes 2030: Amended Final Terms
12th Nov 202511:20 amRNSLendInvest III 8.25% Notes: Results & Final Terms
11th Nov 202510:01 amRNSLENDINVEST 8.25% NOTES 2030: OFFER CLOSING EARLY
4th Nov 20259:29 amRNSLendInvest: Notification of Major Holdings change
4th Nov 20259:26 amRNSLendInvest: Notification of major holdings change
28th Oct 202512:23 pmRNSLendInvest Closes £310m RMBS Securitisation
14th Oct 20255:11 pmRNSLENDINVEST ANNOUNCE LAUNCH OF 8.25% NOTES DUE 2030
14th Oct 20254:56 pmRNSExchange Offer Memorandum, Prospectus & Final Term
14th Oct 202510:49 amRNSPublication of a Base Prospectus
2nd Oct 20251:11 pmRNSLendInvest Secured Income 3 Roadshow Announcement
9th Sep 20255:06 pmRNSAGM Statement
7th Aug 20251:00 pmRNSPublication of FY25 Annual Report & notice of AGM
31st Jul 20257:00 amRNSDirector/PDMR Shareholding
21st Jul 20257:43 amRNSAnnual Financial Report
3rd Mar 20257:00 amRNSLendInvest Board Changes
27th Jan 20257:00 amRNSLendInvest grows Funds under Management to £5.14bn
17th Dec 20243:49 pmRNSChange of Registered Office
9th Dec 20247:00 amRNSHalf-year Report
7th Nov 20247:00 amRNSLendInvest Closes £285M UK Mortgage Securitisation
5th Nov 20244:28 pmRNSDirector/PDMR Shareholding
25th Oct 20249:31 amRNSHolding(s) in Company
25th Oct 20249:30 amRNSDirector/PDMR Notification
21st Oct 20247:00 amRNSLendInvest Secures £300m from BNP, Barclays, HSBC
24th Sep 20242:42 pmRNSResult of AGM
10th Sep 20247:00 amRNSLendInvest signs £1.5bn funding deal with JPMorgan
6th Sep 202411:53 amRNSPDMR Dealing
20th Aug 202411:42 amRNSIssue of Shares to EBT and Total Voting Rights
14th Aug 202411:32 amRNSPublication of Annual Report and Notice of AGM
31st Jul 20247:00 amRNSBoard Changes
24th Jul 20247:05 amRNSLendInvest plc Full Year Financial Results FY24
17th Jun 20247:00 amRNSUpdate on FY24 guidance
4th Jun 20249:58 amRNSBoard Changes
4th Jun 20247:01 amRNSLendInvest successfully closes funding transaction
4th Jun 20247:00 amRNSBoard Changes
18th Apr 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.